Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$36.71 - $44.15 $2.77 Million - $3.33 Million
75,508 Added 3.52%
2,218,827 $92.3 Million
Q1 2023

May 15, 2023

BUY
$36.81 - $48.12 $904,164 - $1.18 Million
24,563 Added 1.16%
2,143,319 $88.5 Million
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $10.2 Million - $12.8 Million
285,974 Added 15.6%
2,118,756 $87.4 Million
Q3 2022

Nov 15, 2022

BUY
$42.51 - $54.02 $2.57 Million - $3.27 Million
60,552 Added 3.42%
1,832,782 $80.3 Million
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $19,813 - $25,274
423 Added 0.02%
1,772,230 $87.1 Million
Q1 2022

May 16, 2022

BUY
$48.09 - $57.79 $1.49 Million - $1.79 Million
30,972 Added 1.78%
1,771,807 $100 Million
Q4 2021

Feb 14, 2022

BUY
$47.19 - $62.68 $1.27 Million - $1.68 Million
26,870 Added 1.57%
1,740,835 $91.4 Million
Q3 2021

Nov 15, 2021

BUY
$56.91 - $67.81 $691,399 - $823,823
12,149 Added 0.71%
1,713,965 $103 Million
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $2.23 Million - $2.49 Million
34,787 Added 2.09%
1,701,816 $115 Million
Q1 2021

May 17, 2021

SELL
$53.26 - $68.08 $4.61 Million - $5.89 Million
-86,514 Reduced 4.93%
1,667,029 $109 Million
Q4 2020

Feb 16, 2021

BUY
$43.41 - $56.51 $2.11 Million - $2.74 Million
48,516 Added 2.85%
1,753,543 $98.8 Million
Q3 2020

Nov 10, 2020

SELL
$47.43 - $60.75 $4.17 Million - $5.34 Million
-87,926 Reduced 4.9%
1,705,027 $82.8 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $1.5 Million - $2.3 Million
34,567 Added 1.97%
1,792,953 $99.8 Million
Q1 2020

May 11, 2020

BUY
$32.82 - $81.13 $57.7 Million - $143 Million
1,758,386 New
1,758,386 $89.1 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.